Читать «Будущее медицины: Ваше здоровье в ваших руках» онлайн - страница 237
Эрик Тополь
27. A. Schaffer, "Too Much Information,"
28. A. D. Marcus, "Genetic Testing Leaves More Patients Living in Limbo,"
29. B. Wilcken, "Newborn Screening: Gaps in the Evidence,"
30. E. Gabler, "Delays at Hospitals Across the Country Undermine Newborn Screening Programs, Putting Babies at Risk of Disability and Death,"
31. R. Greenfield, "Tracked Since Birth: The Rise of Extreme Baby Monitoring,"
32. D. Epstein,
33. W. Koh et al., "Noninvasive In Vivo Monitoring of Tissue-Specific Global Gene Expression in Humans,"
34. A. R. McLean, "Coming to an Airport Near You,"
35. M. R. Wilson et al., "Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing,"
36. J. N. Weinstein et al., "The Cancer Genome Atlas Pan-Cancer Analysis Project,"
37. G. Frampton et al., "Development and Validation of a Clinical Cancer Genomic Profiling Test Based on Massively Parallel DNA Sequencing,"
38. J. Couzin-Frankel, "Cancer Immunotherapy,"
39. A. L. Williams et al., "Sequence Variants in SLC16A11 Are a Common Risk Factor for Type 2 Diabetes in Mexico,"
40. J. C. Florez et al., "Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population,"
41. I. Moltke et al., "A Common Greenlandic TBC1D4 Variant Confers Muscle Insulin Resistance and Type 2 Diabetes,"
42. A. R. Harper and E. J. Topol, "Pharmacogenomics in Clinical Practice and Drug Development,"
43. C.-H. Chen et al., "Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder,"
44. A. B. Jorgensen et al., "Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease,"
